Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Van who wrote (60)	3/26/1998 10:19:00 AM
From: Gwolf	Read Replies (1) \| Respond to of 6039

Van, CTI needs to have a total of 600 patients, 300 benign and 300 malignant to complete the FDA trials. The last thing I heard was that they had about 100 more total to go. They expect to complete these trials in late May or early June, but please note that it is solely dependant on women coming to these hospitals and requesting a breast examination. If California has an earthquake the last thing on a women's mind will be to get a breast scan, on the other hand if Oprah Winfrey does a program on breast cancer then women requesting one will surge ahead, well you get the picture. CTI has filed a registration statement with the SEC. This registration is a comprehensive breakdown of CTI and explains what has occurred in the company's business and their financial structure. Until the SEC reviews and accepts the registration they are in what is known as " The Quite Period " where they are not allowed to make any " Forward Looking Statements". In other words they can't tell us much about what is occurring in the company until the quite period is over, after that they can. Van it's always nice to see someone new on this thread, I hope the post on this thread will help you in your quest for information on CTI, glad to have you on board. Gwolf